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ABSTRACT 
Objective: This study aimed to develop validated targets to be employed in structure-based virtual screening (SBVS) to discover ligands for the 
human histamine H2 receptor (hHRH2). 
Methods: The virtual targets construction was initiated by homology modeling with the reference compound ranitidine as the ligand followed by 
100 ns molecular dynamics (MD) simulations. During MD simulations, the snapshot with the lowest value of the free energy of binding was selected 
for further validation by re-docking simulations. All simulations were performed in YASARA-Structure. 
Results: The research presented here resulted in one validated target for the SBVS. Additionally, by employing a clustering module in MD 
simulations analysis in YASARA-Structure, more than ten different virtual targets are also available for further uses. 
Conclusion: The virtual targets resulted in this research offer possibilities to construct valid SBVS protocols to identify ligands for the hHRH2. 
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Histamine H2 receptor (HRH2) plays an essential role in regulating 
gastric acid, the secretion of which facilitates protein digestion [1]. 
The receptor contributes to the absorption of micronutrients and 
certain drugs, eliminating ingested microorganisms and preventing 
bacterial overgrowth and enteric infections [2]. Receptor therapy 
contributes in treating peptic ulcers and gastro-oesophageal reflux 
disease (GORD) [1]. This disease is a global health epidemic, with 
billions of people suffering from gastric disorders to gastric cancer 
[3].  
Due to these significant roles, it is necessary to perform research 
regarding the human HRH2 (hHRH2) as the target of drug discovery 
projects [4]. One of the effective methods in the computer-assisted 
discovery of new drugs is structure-based virtual screening (SBVS) [5]. 
The approach is efficient for the design, discovery, and optimization of 
bioactive compounds [6] and is capable of generating directions for 
further drug development [7], projecting the ligand binding pose, 
estimating its affinity for the target protein [8], modeling accurate 
structures, and predicting activity precisely [9]. 
The main instrument used in this study was a hardware with Intel® 
Xeon 2680 V3 as the processor, Nvidia Quadro M4000 as the video 
graphic card, 500Gb SSD, 64Gb ECC Registered RAM. The operating 
system was Ubuntu 20.04.1 LTS, and the main software was 
YASARA-Structure 20.1.2410 [10]. The primary material used in this 
research was the crystal structure of the human histamine H1 
receptor (hHRH1) [11] (PDB ID: 3RZE) obtained from 
https://www.rcsb.org/structure/3RZE. The reference compound 
structure, i.e., ranitidine was taken from 
https://www.go.drugbank.com/drugs/DB00863, while the hHRH2 
target sequence was obtained from 
https://www.uniprot.org/uniprot/P25021. 
Homology modeling hHRH2 were run with YASARA-structure 
through the module “Homology modeling”. The hHRH1 crystal 
structure was used as the template, which consisted of 397 amino 
acid residues. Alignment correction and loop modeling were 
performed by predicting secondary structures for target sequences 
using PSI-BLAST, then they were included in the PSI-Pred secondary 
structure prediction algorithm [12]. Five homologous models 
resulted from the homology modeling were then sorted by Z-score. 
Subsequently, YASARA-structure combines the best parts of the five 
models to get a hybrid model with increased accuracy beyond each 
contributor, shown in table 1. A total 327 of the 397 target residues 
(82.4%) were aligned with the template residues, the order identity 
was 24.5%, and the sequence similarity was 45.0%. 
 
Table 1: Result of the hybrid model obtained the following quality Z-scores 
Check type Quality Z-score Comment 
Dihedrals  0.034 Optimal 
Packing 1D -0.735 Good 
Packing 3D -1.437 Satisfactory 
Overall -0.950 Good 
 
The selected receptor homology model was used as the target for 
ranitidine docking, performed 1,000 times, and iterated 25 times 
using the VINA method. Molecular docking simulations were run 
with YASARA-Structure by using the dock_run.mcr command which 
is provided default by YASARA-Structure. Thirteen suggested ligand-
receptor complexes were ordered based on the best free energy of 
binding. Since the molecular docking simulation provided visual 
information of the protein-ligand interactions [13], visual inspection 
played an important role in the pose selection. According to Shin et 
al., Asp98 in hHRH2 was fundamental for binding of essential 
antagonists [14]. Therefore, based on the visual inspection, the 
docking pose of number 12 was selected with the binding energy of-
7.290 kcal/mol.  
Molecular dynamics (MD) simulations of the complex embedded in 
the membrane were then carried out to obtain an overview of the 
most stable ligand-receptor bond pose [16], were run with YASARA-
Structure by employing the md_runmembrane.mcr command which 
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is provided default by YASARA-Structure. The MD simulations were 
carried out with the following settings: The force field AMBER14, pH 
7.4, temperature 298K, pressure 1 bar. Simulations were run at up to 
100 ns, and simulation snapshots were stored at 100 ps intervals. 
The snapshots were then analyzed to examine the structural 
stability and the free energy of binding. 
The MD simulations showed that the RMSD values remained 
constant since 5 ns. (fig. 1. a). Delta RMSD values were calculated 
every 5 ns, and the data shows that most of the times the values 
are less than 1 Å (fig. 1. b), which indicates that the system was 
stable. According to Liu et al., stability is achieved if RMSD 
values' deviation in the last 5 ns in the MD simulation is less than 
1 Å [15]. 
The free energy of binding in MD simulation is calculated using VINA 
embedded in YASARA-Structure (fig. 2). The most stable system was 
formed at the 838 picosecond time interval with the free energy of 
binding value of-9.654 kcal/mol. This system was selected and 
analysed further as validated virtual target (fig. 3). 
Thermodynamically, the best receptor-ligand interactions occur if 
the resulting complex has lower potential energy [16] 
  
 
Fig. 1: a RMSD (Å) vs. Time (ns) graph, 1. b. Delta RMSD (Å) vs. Time (ns) graph 
 
.  
Fig. 2: The free energy of binding (kcal/mol) vs time (ns) graph 
 
The validation was carried out by re-docking the receptor-ligand 
complex at snapshot 838 for 1000 times with 25 iterations. The ligand 
pose resulting from re-docking was compared to the reference ligand 
pose and the RMSD values were calculated [17]. The simulation of 
repeated docking 1000 times resulted in all RMSD data generated 
having a value of less than 2 Å, indicating that the resulting confidence 
level satisfies the rule [18]. This value is the first step in developing a 
quality structure-based virtual screening protocol [17] to identify 
histamine H2 inhibitors. Subsequently, in order to have 10 cluster 
systems, clusterization of the molecular dynamics simulation results 
was carried out by using 3.6 Å as the minimum RMSD of snapshots 
between clusters. The clusterization was intended to provide more 
virtual targets for further development of structure-based screening in 
the discovery of hHRH2 ligands. 
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Fig. 3: a The most stable system at the 838 picosecond time interval, 3. b Visual inspection of the interaction of ranitidine to Asp98 
 
FUNDING 
This research was funded by Institute for Research and Community 
Services, Universitas Sanata Dharma (Research Grant Contract No. 
013/Penel./LPPM-USD/II/2021). 
AUTHORS CONTRIBUTIONS  
G. N. conducted all the computational simulations, and E. P. I 
supervised the work. G. N. initiated the original draft of the 
manuscript. E. P. I reviewed and edited the manuscript. All 
authors have given approval to the final version of the 
manuscript.  
CONFLICTS OF INTERESTS  
All authors have none to declare.  
REFERENCES 
1. E Tiligada, M Ennis. Histamine pharmacology: from Sir Henry 
Dale to the 21st century. Br J Pharmacol 2020;177:1–21. 
2. ML Schubert, JF Rehfeld. Gastric peptides-gastrin and 
somatostatin. Compr Physiol 2020;10:1–32. 
3. A Lanas, FKL Chan. Peptic ulcer disease. Lancet 2017;390:1–12. 
4. G Nugraha, EP Istyastono. Pembuatan protokol penapisan virtual 
berbasis stuktur (PVBS) untuk identifikasi ligan inhibitor 
reseptor platelet-activating factor (PAF-r) sebagai target 
terapeutik ssma menggunakan YASARA. J Ris Kim 2020;11:35–
42. 
5. CN Cavasotto, AJW Orry. Ligand docking and virtual screening 
in structure-based drug discovery. Curr Top Med Chem 
2007;7:1006–14. 
6. A Hinchliffe. Molecular modelling for beginners. 2nd John Wiley 
and Sons Ltd, Weinheim, Germany; 2008. 
https://doi.org/10.1365/s10337-009-1412-5. 
7. L Tan, H Geppert, MT Sisay, M Gütschow, J Bajorath. Integrating 
structure-and ligand-based virtual screening: comparison of 
individual, parallel, and fused molecular docking and similarity 
search calculations on multiple targets. Chem Med Chem 
2008;3:1–6. 
8. RT Kroemer. Structure-based drug design: docking and scoring. 
Curr Protein Pept Sci 2007;8:1–18. 
9. AR Leach, BK Shoichet, CE Peishoff. Docking and scoring. Am 
Chem Soc 2006;49:1–5. 
10. E Krieger, G Koraimann, G Vriend. Increasing the precision of 
comparative models with YASARA NOVA-a self-parameterizing 
force field. Proteins Struct Funct Genet 2002;47:1–10. 
11. T Shimamura, M Shiroishi, S Weyand, H Tsujimoto, G Winter, V 
Katritch, et al. structure of the human histamine H1 receptor 
complex with doxepin. Nature 2011;475:1–8. 
12. DT Jones. Protein secondary structure prediction based on 
position-specific scoring matrices. J Mol Biol 1999;292:1–8. 
13. T Lengauer, M Rarey. Computational methods for biomolecular 
docking. Curr Opin Struct Biol 1996;6:1–5. 
14. N Shin, E Coates, NJ Murgolo, KL Morse, M Bayne, CD Strader, et 
al. Molecular modeling and site-specific mutagenesis of the 
histamine-binding site of the histamine H4 receptor. Mol 
Pharmacol 2002;62:1–10. 
15. K Liu, E Watanabe, H Kokubo. Exploring the stability of ligand 
binding modes to proteins by molecular dynamics simulations. 
J Comput Aided Mol Des 2017;31:1–10. 
16. G Schneider. De novo molecular design, Wiley-VCH Verlag 
GmbH and Co., Weinheim, Germany; 2014. 
17. EP Istyastono. Construction, validation and application of 
structure-based virtual screening protocols to discover new 
cyclooxygenase-2 inhibitors. Indo J Chem 2012;12:1–5. 
18. G Marcou, D Rognan. Optimizing fragment and scaffold docking 
by use of molecular interaction fingerprints. J Chem Inf Model 
2007;47:1–13. 
 
